Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/11/2003US6531312 Isolated nucleic acid of given sequence
03/11/2003US6531307 Capable of activating a compound with little or no toxicity into an active product; use in treating viral diseases, cancer, and genetic disorders
03/11/2003US6531306 Polynucleotides encoding mammalian DNA-dependent ATPase A polypeptides
03/11/2003US6531298 Factor IX antihemophilic factor with increased clotting activity
03/11/2003US6531295 Isolated nucleic acid encoding polypeptide of given amino acid sequence which serves as a glycosaminoglycan attachment site for heparan sulfate chain
03/11/2003US6531292 Genes and proteins controlling cholesterol synthesis
03/11/2003US6531280 Method for identifying or isolating a molecule and molecules identified thereby
03/11/2003US6531276 Using probes to determine duplex formation; use in diagnostic, prophylactic, and therapeutic applications
03/11/2003US6531136 Equine rhinovirus 1 proteins
03/11/2003US6531134 Mammalian milk growth factor
03/11/2003US6531133 Pseudomonas exotoxin-myelin basic protein chimeric proteins
03/11/2003US6531130 Treatment of demyelinating autoimmune disease with ordered peptides
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531128 Methods for treating glaucoma
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003US6531125 Proteins having A and B chains of a ricin-like toxin, linked by a linker sequence which is specifically cleavable by a retroviral protease to release the active A chain
03/11/2003US6531122 Nterferon beta polypeptide variant exhibiting an interferon beta activity, comprising a variant sequence which differs from the wildtype human interferon beta sequence in no more than 15 amino acid residues
03/11/2003US6531121 Protection and enhancement of erythropoietin-responsive cells, tissues and organs
03/11/2003US6531112 Formulations for administering calcitonin and processes for preparing the same
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/11/2003CA2100720C Medicinal composition comprising tcf-ii
03/10/2003CA2369250A1 Novel anti-viral and anti-proliferative agents derived from stat1 transcription factor
03/06/2003WO2003019457A2 Method of optimizing growth hormone replacement
03/06/2003WO2003019136A2 Methods for inhibiting angiogenesis
03/06/2003WO2003018847A1 Effect of bdnf genotype on hippocampal function and verbal memory and risk for schizophrenia
03/06/2003WO2003018842A1 Novel gene nedl-1
03/06/2003WO2003018836A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease
03/06/2003WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas
03/06/2003WO2003018821A2 Compositions and methods for treating neurodegenerative diseases
03/06/2003WO2003018817A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003WO2003018815A2 Regulation of human g protein-couple receptor kinase
03/06/2003WO2003018812A1 Regulation of human ptpase-like protein
03/06/2003WO2003018811A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003WO2003018806A1 Novel human bmcc1 gene
03/06/2003WO2003018805A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
03/06/2003WO2003018804A1 Proteins having effects of controlling cell migration and cell death
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018795A1 Novel rfrp-3 and dna thereof
03/06/2003WO2003018793A1 Novel gene having guanine nucleotide exchange factor-like sequence
03/06/2003WO2003018788A2 Improved nitroreductase enzymes
03/06/2003WO2003018782A2 Differentiation of neural stem cells and therapeutic use theeof
03/06/2003WO2003018781A1 Regulation of cytotrophoblast cell differentiation and cell migration
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018755A2 Wild-type ras as a cancer therapeutic agent
03/06/2003WO2003018754A2 Neural regeneration peptide and methods for their use in treatment of brain damage
03/06/2003WO2003018748A2 Anti-cancer and wound healing compounds
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
03/06/2003WO2003018620A2 Serine protease inhibitor and processes for the preparation thereof
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018618A2 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds
03/06/2003WO2003018617A1 Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
03/06/2003WO2003018615A1 Novel crystal of cyclic lipopeptide compound
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018610A2 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
03/06/2003WO2003018609A2 Application of peptide conjugates to alzheimer's disease
03/06/2003WO2003018608A2 Process for purifying glycopeptide phosphonate derivatives
03/06/2003WO2003018607A2 Process for preparing glycopeptide derivatives
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018600A2 Antisense modulation of microsomal triglyceride transfer protein expression
03/06/2003WO2003018595A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003WO2003018539A1 Amphoteric lipid compound and use thereof
03/06/2003WO2003018516A2 Glucagon-like peptide-1 analogs
03/06/2003WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003WO2003018065A1 Anti-cancer agents comprising disintegrin genes and the treating methods
03/06/2003WO2003018064A2 Lipophilic drug compositions
03/06/2003WO2003018059A2 Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
03/06/2003WO2003018053A1 Vaccine against mycobacterial-induced diseases
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003018050A1 Gamma three protease
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018048A1 Use of hla class 1 soluble molecules to inhibit angiogenesis
03/06/2003WO2003018047A2 Hdl for the treatment of stroke and other ischemic conditions
03/06/2003WO2003018046A1 Crystals of luxp and complexes thereof
03/06/2003WO2003018045A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018035A1 Pharmaceutical preparation for treating wounds
03/06/2003WO2003018028A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture
03/06/2003WO2003017989A1 Compositions and techniques for localized therapy of restenosis
03/06/2003WO2003017987A1 Biodegradable polymeric nanocapsules and uses thereof
03/06/2003WO2003017947A2 Spontaneous emulsions containing cyclosporine
03/06/2003WO2003017944A2 Gpi-anchored cytokines
03/06/2003WO2003017943A2 Therapeutic compositions and methods for treating viral infection
03/06/2003WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
03/06/2003WO2003017924A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/06/2003WO2003017923A2 Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same
03/06/2003WO2003017922A2 Use of substances with oxytocin activity for the preparation of a pharmaceutical composition against inflammation
03/06/2003WO2003017920A2 Protective factors against inflammation, burns and noxious stimuli
03/06/2003WO2003017917A2 Use of microbiology non-viral substances for treating acne
03/06/2003WO2003017825A2 Methods of treating obesity
03/06/2003WO2003017817A2 Diagnosis, prevention and treatment of cancer
03/06/2003WO2003017787A1 Dipeptides for prevention of muscle breakdown and microbial infection
03/06/2003WO2003017780A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
1 ... 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 ... 3163